{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:47:07Z","timestamp":1749066427874},"reference-count":9,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.transproceed.2017.09.057","type":"journal-article","created":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T22:50:41Z","timestamp":1521586241000},"page":"631-633","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Therapy With Direct-Acting Antiviral Agents for Hepatitis C in Liver Transplant Recipients"],"prefix":"10.1016","volume":"50","author":[{"given":"F.","family":"Nogueras L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"L\u00f3pez Garrido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.J.","family":"Ortega Suazo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Vadillo Calles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Valverde L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.D.","family":"Espinosa Aguilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.transproceed.2017.09.057_bib1","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","article-title":"Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)","volume":"57","author":"Adam","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.transproceed.2017.09.057_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/01.mot.0000161761.40866.12","article-title":"Hepatitis C after liver transplantation: risk factors, outcomes and treatment","volume":"10","author":"Berenguer","year":"2005","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.transproceed.2017.09.057_bib3","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/hep.27681","article-title":"Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation","volume":"61","author":"Forns","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2017.09.057_bib4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.gastro.2014.10.001","article-title":"Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation","volume":"148","author":"Charlton","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.transproceed.2017.09.057_bib5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/liv.13017","article-title":"News and challenges in the treatment of hepatitis C in liver transplantation","volume":"36","author":"Coilly","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.transproceed.2017.09.057_bib6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/TP.0000000000000860","article-title":"Interferon-free therapy for hepatitis C in liver transplant recipients","volume":"100","author":"Ueda","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2017.09.057_bib7","article-title":"Ombitasvir\/paitaprevir\/ and dasabuvir with or without ribavirin for HCV patients with post-transplant recurrence","author":"Mantry","year":"2015","journal-title":"AASLD"},{"key":"10.1016\/j.transproceed.2017.09.057_bib8","article-title":"Sofosbuvir+ledipasvir combination therapy for recurrent hepatitis C in liver transplant recipients: a real-life multicenter experience","author":"Kwok","year":"2015","journal-title":"AASLD"},{"key":"10.1016\/j.transproceed.2017.09.057_bib9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/lt.24366","article-title":"Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: real-world experience from the hepatitis C therapeutic registry and research network","volume":"22","author":"Brown","year":"2016","journal-title":"Liver Transpl"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134517309156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134517309156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T16:48:22Z","timestamp":1530550102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134517309156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0041134517309156"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2017.09.057","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapy With Direct-Acting Antiviral Agents for Hepatitis C in Liver Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2017.09.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}